Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History VRNA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics VRNA

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Verona Pharma PLC ADR

VRNA
Current price
104.90 USD +0.13 USD (+0.12%)
Last closed 104.74 USD
ISIN US9250501064
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 8 900 688 896 USD
Yield for 12 month +357.08 %
1Y
3Y
5Y
10Y
15Y
VRNA
21.11.2021 - 28.11.2021

Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company offers Ohtuvayre, a dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that combines bronchodilator and non-steroidal anti-inflammatory effects for the maintenance treatment of chronic obstructive pulmonary disease, as well as cystic fibrosis and asthma. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom. Address: 3 More London Riverside, London, United Kingdom, SE1 2RE

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

119.09 USD

P/E Ratio

Dividend Yield

Financials VRNA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures VRNA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+42 279 000 USD

Last Year

+458 000 USD

Current Quarter

+76 256 000 USD

Last Quarter

+36 655 000 USD

Current Year

+39 697 000 USD

Last Year

-679 624 USD

Current Quarter

+72 849 000 USD

Last Quarter

+34 616 000 USD
EBITDA -133 641 000 USD
Operating Margin TTM -13.53 %
Price to Earnings
Return On Assets TTM -20.64 %
PEG Ratio
Return On Equity TTM -72.61 %
Wall Street Target Price 119.09 USD
Revenue TTM 118 535 000 USD
Book Value 2.66 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 112 546 000 USD
Earnings per share -2.00 USD
Diluted Eps TTM -2.00 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -138.31 %

Stock Valuation VRNA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 476.19
Enterprise Value Revenue 73.90
Price Sales TTM 75.09
Enterprise Value EBITDA -20.89
Price Book MRQ 39.35

Technical Indicators VRNA

For 52 Weeks

18.51 USD 104.99 USD
50 Day MA 83.76 USD
Shares Short Prior Month 8 415 794
200 Day MA 57.97 USD
Short Ratio 6.19
Shares Short 7 208 170
Short Percent 10.31 %